|
Market Closed -
Euronext Paris
11:55:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.4635 EUR | +1.20% |
|
-1.38% | +18.54% |
| 10-06 | WINNERS & LOSERS: Celebrus warning; Kenmare gets takeover interest | AN |
| 09-30 | Novacyt S.A., H1 2026 Earnings Call, Sep 30, 2026 |
Company Valuation: Novacyt
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 309.3 | 86.78 | 42.47 | 27.57 | 33.6 | - |
| Change | - | -71.94% | - | -35.08% | 21.89% | - |
| Enterprise Value (EV) 1 | 190.3 | 86.78 | 42.47 | 17.5 | 35.56 | 38.45 |
| Change | - | -54.41% | - | -58.79% | 103.2% | 8.12% |
| P/E | - | -3.01x | -0.87x | - | - | - |
| PBR | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - |
| Capitalization / Revenue | 2.72x | - | - | 1.19x | 1.1x | 0.96x |
| EV / Revenue | 1.67x | - | - | 0.75x | 1.16x | 1.1x |
| EV / EBITDA | 4.32x | - | - | -1.94x | -5.17x | -14.1x |
| EV / EBIT | 4.57x | - | - | -1.33x | -3.56x | -7.29x |
| EV / FCF | - | - | - | -1.59x | -3.97x | -8.87x |
| FCF Yield | - | - | - | -62.7% | -25.2% | -11.3% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | - | -0.408 | -0.6934 | - | - | - |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 113.8 | - | - | 23.18 | 30.52 | 34.86 |
| EBITDA 1 | 44.06 | - | - | -9.014 | -6.878 | -2.727 |
| EBIT 1 | 41.68 | - | - | -13.13 | -10 | -5.273 |
| Net income | - | -29.16 | -49.07 | - | - | - |
| Net Debt 1 | -119 | - | - | -10.07 | 1.956 | 4.842 |
| Reference price 2 | 4.3800 | 1.2295 | 0.6020 | 0.3910 | 0.4635 | 0.4635 |
| Nbr of stocks (in thousands) | 70,616 | 70,582 | 70,547 | 70,511 | 72,502 | - |
| Announcement Date | 4/28/22 | 4/27/23 | 4/30/25 | 4/30/26 | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 1.16x | -5.17x | - | 37.63M | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 7.93x | 26.43x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| Average | 26.77x | 23.92x | 13.62x | 0.32% | 38.32B | |
| Weighted average by Cap. | 26.72x | 25.31x | 15.93x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALNOV Stock
- Valuation Novacyt
Select your edition
All financial news and data tailored to specific country editions
